0
0
Home » Medical Devices » Cardiovascular Devices

Coronary Stents Market Size (Value, Volume, ASP) by Segments, Share, Trend and SWOT Analysis, Regulatory and Reimbursement Landscape, Procedures, and Forecast, 2015-2030

Coronary Stents Market Size (Value, Volume, ASP) by Segments, Share, Trend and SWOT Analysis, Regulatory and Reimbursement Landscape, Procedures, and Forecast, 2015-2030 is built to visualize quantitative market trends within Cardiovascular Devices therapeutic area.

The model discusses in detail the impact of COVID-19 on Coronary Stents market for the year 2020 and beyond. US has some of the highest rates of AP and MI. However, according to secondary sources the prevalence of heart disease is decreasing. This decline may be due to preventative efforts such as lifestyle changes and reduction in smoking. In regions, such as the Middle East for example the prevalence of heart disease is increasing. The global increase in heart disease can be attributed to risk factors and comorbidities such as diabetes, hypertension, obesity, and tobacco use. Moreover, as many of these comorbidities are closely tied to age, the growing elderly population will also contribute to the rising disease prevalence. Overall, urbanization has led to increased smoking rates, lack of physical activity and unhealthy lifestyle. The Coronary Stents Market is segmented into Bare Metal Stents, Drug Eluting Stents (DES), Covered Stents, Bioabsorbable Stents (BAS).

Each of the covered 39 country’s color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are –

Currently marketed Coronary Stents market and evolving competitive landscape –

  • Insightful review of the key industry trends.
  • Annualized total Coronary Stents market revenue by segment and market outlooks from 2015-2030.
  • Granular data on total procedures, units, average selling prices and market values by segment.

Global, Regional and Country level market specific insights –

  • Qualitative market specific information is available with global trends further broken down into regional trends. In addition GlobalData analysts provide unique country specific insights on the market.
  • SWOT analysis for Coronary Stents market.
  • Competitive dynamics insights and trends provided Coronary Stents market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

  • Country specific overview of the healthcare system.
  • Country specific reimbursement policies.
  • Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered: Boston Scientific Corporation, Abbott Laboratories, Medtronic plc, Biotronik AG, Lepu Medical Technology (Beijing) Co Ltd, B. Braun Melsungen AG, MicroPort Scientific Corp, Sahajanand Medical Technologies Pvt Ltd, Meril Life Sciences Pvt Ltd, Translumina Therapeutics LLP, Vascular Concepts Ltd., Others

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.

Scope of the Coronary Stents market model

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Currently marketed Coronary Stents and evolving competitive landscape:

  • Insightful review of the key industry trends.
  • Annualized total coronary stents market revenue by segment and market outlooks from 2015-2030.
  • Granular data on total procedures, units, average selling prices and market values by segment
  • Global, Regional and Country level market specific insights includes qualitative market specific information is available with global trends further broken down into regional trends. In addition, GlobalData analysts provide unique country-specific insights on the market.
  • SWOT analysis for coronary stents market.
  • Competitive dynamics insights and trends provided for coronary stents market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape:

  • Country specific overview of the healthcare system.
  • Country specific reimbursement policies.
  • Country specific medtech regulatory landscape.

What is the Coronary Stents market size during the historical and forecast period?

Coronary Stents market, by segment

Coronary Stents market, by segment

For more segment insights, download a free report sample

What are the key trends within the Coronary Stents market?

In North America, the most dominant market is the US. The coronary stents market is mostly driven by DES devices. The US and Canada will see stable growth in the Coronary Stent market.

Coronary stents will continue to be widely used in clinical practice in the European markets because of their increased safety and efficacy. However, growth in the stenting procedures will be low in major European countries, as stenting rates are already high in these markets.

The use of PCI is increasing in the Asia-Pacific region due to an ageing population, better screening and diagnosis, growing demand to address unmet needs in the population, improved patient access to healthcare, lower prices, increasing physician and patient awareness of minimally invasive cardiovascular procedures and the improved outcomes of stenting procedures.

With the improving healthcare infrastructures and broadening of distribution networks, the coronary market is expected to grow in South & Central America.

GlobalData expects the growth of coronary stenting procedures in the Middle East & Africa. The increasing prevalence of heart disease, a growing aging population, and increasing investments in the healthcare infrastructure will drive the market.

Coronary Stents market report scope

  Market value (Year – 2021)   $4,819.6 million
  Segmentation by sector Bare Metal Stents, Bioabsorbable Stents, Covered Stents, and Drug Eluting Stents
  Key companies Boston Scientific Corporation, Abbott Laboratories, Medtronic plc, Biotronik AG, Lepu Medical Technology (Beijing) Co Ltd, B. Braun Melsungen AG, MicroPort Scientific Corp, Sahajanand Medical Technologies Pvt Ltd, Meril Life Sciences Pvt Ltd, Translumina Therapeutics LLP, and Vascular Concepts Ltd.
Regions covered North America, South & Central America, Europe, Middle East & Africa, Asia-Pacific
  Countries covered United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina and Chile

Who are the Coronary Stents market vendors?

The model analyses the competitive landscape of the coronary stents market and includes information on the following key market vendors:

Boston Scientific Corporation, Abbott Laboratories, Medtronic plc, Biotronik AG, Lepu Medical Technology (Beijing) Co Ltd, B. Braun Melsungen AG, MicroPort Scientific Corp, Sahajanand Medical Technologies Pvt Ltd, Meril Life Sciences Pvt Ltd, Translumina Therapeutics LLP, and Vascular Concepts Ltd.

Scope

This Market Model gives important, expert insight you won’t find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for –

– CMO executives who must have deep understanding of the Coronary stents marketplace to make strategic planning and investment decisions.

– Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.

– Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to –

– Understand the impact of COVID-19 on Coronary Stents market.

– Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.

– Develop business strategies by understanding the trends shaping and driving Coronary Stents market.

– Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Coronary Stents market in the future.

– Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.

– Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.

– Track device sales in the global and country-specific Coronary Stents market from 2015-2030.

– Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.

Key Players

Boston Scientific Corporation

Abbott Laboratories

Medtronic plc

Biotronik AG

Lepu Medical Technology (Beijing) Co Ltd

B. Braun Melsungen AG

MicroPort Scientific Corp

Sahajanand Medical Technologies Pvt Ltd

Meril Life Sciences Pvt Ltd

Translumina Therapeutics LLP

Vascular Concepts Ltd.

Others

Frequently Asked Questions

The coronary stents market in 2021 is worth $4,819.6 million.

The coronary stents market has been segmented by product (Bare Metal Stents, Bioabsorbable Stents, Covered Stents, and Drug Eluting Stents) and by 5 regions (North America, South & Central America, Europe, Middle East & Africa and Asia-Pacific) and 39 countries.

Key players in the coronary stents market include Boston Scientific Corporation, Abbott Laboratories, Medtronic plc, Biotronik AG, Lepu Medical Technology (Beijing) Co Ltd, B. Braun Melsungen AG, MicroPort Scientific Corp, Sahajanand Medical Technologies Pvt Ltd, Meril Life Sciences Pvt Ltd, Translumina Therapeutics LLP, Vascular Concepts Ltd., Others.

Drug eluting stents has the largest share of the global coronary stents market by value.

Boston Scientific Corporation has the largest market share in the coronary stents market.

    Pricing

Discounts available for multiple purchases.

reportstore@globaldata.com
+44 20 7947 2960

Join our mailing list

Saved reports